Observational studyBMC infectious diseases2026
Nitroimidazole - albendazole combination therapy, quinacrine use, and risk factors in nitroimidazole-refractory giardiasis: a prospective multicentre observational study.
Kristine Mørch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.